Clinical Trials Logo

Aphasia, Acquired clinical trials

View clinical trials related to Aphasia, Acquired.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06185023 Recruiting - Aphasia Clinical Trials

Effects of High-intensity Exercise Training on Physical Fitness, Cognition, Language in Post-stroke Aphasia

Start date: December 12, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to establish the feasibility and fidelity of a high-intensity exercise program for individuals with post-stroke aphasia. The main questions it aims to answer are: - Is it feasible for stroke survivors with aphasia to participate in a long in-person physical exercise program? - Does participation in a physical exercise program lead to physical fitness, cognitive, language and/or psychological changes? Participants can take part in two different physical exercise interventions: - Low intensity intervention (control intervention); - High-intensity physical exercise intervention (target intervention).

NCT ID: NCT05687994 Recruiting - Aphasia, Acquired Clinical Trials

Speech Entrainment Treatment for People With Aphasia

Start date: January 25, 2023
Phase: N/A
Study type: Interventional

The objective of this research is to experimentally delineate the direct effect of speech entrainment practice on independent speech production and identify practice conditions that enhance treatment benefits. The primary outcome measure (Correct Information Units per minute) tallies informativeness and efficiency of independent speech in treated stories.

NCT ID: NCT05443633 Recruiting - Clinical trials for Primary Progressive Aphasia

Enhancing Language Function in Aphasia

Start date: October 30, 2022
Phase: N/A
Study type: Interventional

Aphasia is an acquired impairment of language, that commonly results from damage to language areas in the brain (typically the left side of the brain). This impairment is seen in many aspects of language, including understanding, speaking, reading and writing. It is estimated that about 2 million individuals are currently living with aphasia in the United States. Further, about 200,000 Americans acquire aphasia every year (National Aphasia Association, 2020). Aphasia poses significant impact on the affected individuals and their families. Behavioral treatments that target language deficits have been shown to enhance overall communication skills and life satisfaction among individuals with aphasia. Although there is evidence that suggests that treatment is efficacious for individuals with aphasia, the extent of improvement long-term coupled with the neural patterns among those individuals are largely unknown. The current study aims to investigate the efficacy of language-based treatment and its corresponding neural patterns.

NCT ID: NCT05113160 Recruiting - Aphasia, Acquired Clinical Trials

Conversation Group Treatment for Aphasia: Does it Work?

Start date: April 15, 2022
Phase: N/A
Study type: Interventional

The proposed research will test the efficacy of group conversation treatment for people with aphasia and explore whether the effects of treatment differ as a result of the following factors: 1. Group size: Do large groups of 6-8 people with aphasia or dyads of 2 people with aphasia demonstrate different levels of improvement with this treatment? 2. Group composition: Do effects of conversation group treatment differ if the groups include members with similar or different types of aphasia? 3. Aphasia severity: Do effects of conversation group treatment differ if the individuals within the group have mild-moderate or moderate-severe profiles of aphasia? Treatment sessions will occur in groups of 6-8 people with aphasia or with 2 people with aphasia. During treatment sessions, discourse will be facilitated on a focused set of every day topics, such as current events or travel. Linguistic and multi modal cueing hierarchies will be tailored to individual client goals and used to maximize communication success. The prediction is that conversation treatment is an effective method for improving communication in people with aphasia, but that specific benefits may differ based on variables such as group size, group composition, and aphasia severity. The results will help inform best practices for aphasia treatment and refine a hypothesized model about the mechanisms underlying conversation treatment.